Results 231 to 240 of about 140,437 (320)
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
Automated project scheduling from UML sequence diagrams using OCR and critical path analysis. [PDF]
Alyami A +3 more
europepmc +1 more source
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra +10 more
wiley +1 more source
MetaXtract: Extracting Metadata from Raw Files for FAIR Data Practices and Workflow Optimisation
Lutfi A +3 more
europepmc +1 more source
Protocol to estimate the heritability of drug response with GxEMM and identify gene-drug interactions with TxEWAS. [PDF]
Sadowski M, Dahl AW, Zaitlen N.
europepmc +1 more source
Effect of chemotherapy on passenger mutations in metastatic colorectal cancer
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui +6 more
wiley +1 more source
AI-HOPE: an AI-driven conversational agent for enhanced clinical and genomic data integration in precision medicine research. [PDF]
Yang EW, Velazquez-Villarreal E.
europepmc +1 more source
Tax Advocacy at Work: Knowing and Executing Your Strategy
Fabio Ambrosio
openalex +1 more source

